1. Coutinho, E.A. and A.S. Kauffman, The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS). Med Sci (Basel), 2019. 7(8).
2. Krishnan, A. and S. Muthusami, Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol, 2017. 232(2): p. R99-R113.
3. Patel, S., Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol, 2018. 182: p. 27-36.
4. Khan, M.J., A. Ullah, and S. Basit, Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Appl Clin Genet, 2019. 12: p. 249-260.
5. Jiao, J., et al., Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome. Hum Reprod, 2018. 33(9): p. 1735-1748.
6. Withdrawal: "Long Non-coding RNA NEAT1 Drives the Development of Polycystic Ovary Syndrome via Sponging Multiple MicroRNAs" by Xia Sang and Yuzhen Zhang. Cell Biol Int, 2020.
7. Ding, N., et al., NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2. Onco Targets Ther, 2017. 10: p. 4905-4915.
8. Chai, Y., et al., HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med, 2016. 5(7): p. 1588-98.
9. Chen, B., et al., The role of MiRNA in polycystic ovary syndrome (PCOS). Gene, 2019. 706: p. 91-96.
10. Jiang, Y.C. and J.X. Ma, The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B. Eur Rev Med Pharmacol Sci, 2018. 22(11): p. 3286-3293.
11. Yuanyuan, Z., et al., Proliferation of Ovarian Granulosa Cells in Polycystic Ovarian Syndrome Is Regulated by MicroRNA-24 by Targeting Wingless-Type Family Member 2B (WNT2B). Med Sci Monit, 2019. 25: p. 4553-4559.
12. Taniguchi, Y., The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Int J Mol Sci, 2016. 17(11).
13. Mao, Z., et al., Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome. J Hum Genet, 2021. 66(2): p. 123-137.
14. Shigeta, S., et al., Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma. Mol Cancer Ther, 2021. 20(4): p. 691-703.
15. Liu, G., et al., lncRNA PVT1/MicroRNA-17-5p/PTEN Axis Regulates Secretion of E2 and P4, Proliferation, and Apoptosis of Ovarian Granulosa Cells in PCOS. Mol Ther Nucleic Acids, 2020. 20: p. 205-216.
16. Kyei, G., et al., Assessing the effect of MitoQ10 and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model. Heliyon, 2020. 6(7): p. e04279.
17. Xia, Y., et al., Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome. Am J Transl Res, 2017. 9(5): p. 2447-2456.
18. Komal, F., et al., Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model. J Transl Med, 2020. 18(1): p. 349.
19. Jiang, B., et al., Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a. J Cell Mol Med, 2020. 24(1): p. 451-464.
20. Li, S.Y., et al., Impaired receptivity and decidualization in DHEA-induced PCOS mice. Sci Rep, 2016. 6: p. 38134.
21. Luo, M., et al., Long noncoding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR1321 and regulating tight junction protein 3 expression. Mol Med Rep, 2020. 22(4): p. 3429-3439.
22. Chen, Z.J., et al., Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer. Eur Rev Med Pharmacol Sci, 2016. 20(16): p. 3373-7.
23. Yuan, L.Y., et al., Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4. J Cell Physiol, 2019. 234(10): p. 18985-18993.
24. Wang, W., et al., LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis. Radiol Oncol, 2019. 53(4): p. 434-442.
25. Liu, Q.Y., et al., Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis. Eur Rev Med Pharmacol Sci, 2020. 24(13): p. 7266-7275.
26. Shi, X., et al., A newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p. Cancer Cell Int, 2020. 20: p. 358.
27. Fang, X., et al., Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3. Cancer Cell Int, 2020. 20: p. 252.
28. Xu, L., et al., Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma. Proc Natl Acad Sci U S A, 2018. 115(22): p. E5086-E5095.
29. Chen, Y.R., et al., BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma. Aging (Albany NY), 2020. 12(17): p. 17541-17567.